Researchers decipher molecular basis of resistance in the African vector Anopheles funestus

November 2, 2015, Liverpool School of Tropical Medicine

Researchers at LSTM have shown the means by which one of the major species of mosquito responsible for transmitting malaria in Africa is becoming resistant to the insecticides used to treat the bednets which protect people from being bitten. This understanding can help tracking resistance and maintaining the effectiveness of tools used to control these mosquitoes.

In a paper published today in the journal PLoS Genetics a team of researchers from LSTM's Department of Vector Biology, collaborating with a colleague at the University of Liverpool, have deciphered the detailed molecular basis of resistance in the African vector Anopheles funestus.

LSTM's Dr Charles Wondji is senior author on the paper and a leading expert in vector genetics. He explained: "It is vital for the continued success of malaria control strategies that we understand, are able to identify and to anticipate the course of pyrethroid resistance in mosquitoes. Without genetic information on insecticide resistance genes and associated molecular markers this is extremely difficult.

He continued: "In this paper we demonstrated that allelic variation in major metabolic resistance genes (CYP6P9a and CYP6P9b) is the key mechanism driving pyrethroid resistance in An. funestus. Furthermore, we showed that three amino acid changes are the causative pyrethroid resistance markers. This information will allow the design of a DNA-based diagnostic assay for the early detection and tracking of resistance in the field as well as an ability to assess the true impact of resistance on malaria transmission and help ensure the continued effectiveness of pyrethroid-based interventions."

Despite the decrease in deaths from malaria in recent decades it remains a very serious public health burden in tropical world, with around 584,000 deaths worldwide in 2013 according to the World Health Organization (WHO), 90% of which were in Africa and mostly in children under the age of five. The scale up of the distribution of Long Lasting Insecticide treated Nets (LLINs) has massively contributed to the reduction in deaths in Africa. However, the success of control programmes is being threatened by growing to pyrethroid insecticides, the only class of insecticide approved by WHO for the use in bednets, among some of the mosquito populations that spread the disease.

Explore further: Professor Janet Hemingway, outlines 15 years of malaria interventions in Africa

More information: Sulaiman S. Ibrahim et al. Allelic Variation of Cytochrome P450s Drives Resistance to Bednet Insecticides in a Major Malaria Vector, PLOS Genetics (2015). DOI: 10.1371/journal.pgen.1005618

Related Stories

Professor Janet Hemingway, outlines 15 years of malaria interventions in Africa

October 8, 2015
In an editorial in the weekly science journal Nature, LSTM's Director, Professor Janet Hemingway, looks at how the last 15 years of control measures have led to massive reductions in disease prevalence in Africa since 2000. ...

How does an insecticide treated bed net actually work?

September 1, 2015
New research from the Liverpool School of Tropical Medicine has revealed precisely how insecticide-treated bed nets are so effective against malaria mosquitoes. 

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.